EP1446416A4 - Anticorps monoclonaux specifiques de tumeur - Google Patents
Anticorps monoclonaux specifiques de tumeurInfo
- Publication number
- EP1446416A4 EP1446416A4 EP02803674A EP02803674A EP1446416A4 EP 1446416 A4 EP1446416 A4 EP 1446416A4 EP 02803674 A EP02803674 A EP 02803674A EP 02803674 A EP02803674 A EP 02803674A EP 1446416 A4 EP1446416 A4 EP 1446416A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- monoclonal antibodies
- specific monoclonal
- tumor specific
- tumor
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98990101A | 2001-11-19 | 2001-11-19 | |
US989901 | 2001-11-19 | ||
PCT/US2002/037134 WO2003044036A1 (fr) | 2001-11-19 | 2002-11-19 | Anticorps monoclonaux specifiques de tumeur |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1446416A1 EP1446416A1 (fr) | 2004-08-18 |
EP1446416A4 true EP1446416A4 (fr) | 2005-11-30 |
Family
ID=25535569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02803674A Withdrawn EP1446416A4 (fr) | 2001-11-19 | 2002-11-19 | Anticorps monoclonaux specifiques de tumeur |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1446416A4 (fr) |
JP (1) | JP2005517388A (fr) |
CN (1) | CN1615315A (fr) |
AU (1) | AU2002365978A1 (fr) |
BR (1) | BR0214288A (fr) |
CA (1) | CA2467020A1 (fr) |
MX (1) | MXPA04004658A (fr) |
WO (1) | WO2003044036A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100166772A1 (en) * | 2007-05-31 | 2010-07-01 | Anderson Annaliesa S | ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n |
JP6323718B2 (ja) | 2011-05-17 | 2018-05-16 | ザ ロックフェラー ユニバーシティー | ヒト免疫不全ウイルスを無毒化する抗体、およびその使用方法。 |
BR112020021271A2 (pt) | 2018-04-17 | 2021-01-26 | Celldex Therapeutics, Inc. | construtos bispecíficos e anticorpos anti- cd27 e anti-pd-l1 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000032635A2 (fr) * | 1998-12-02 | 2000-06-08 | Ixsys, Incorporated | Anticorps monoclonaux humains specifiques de tumeurs et leur technique d'utilisation |
WO2000063699A1 (fr) * | 1999-04-20 | 2000-10-26 | Philogen S.R.L. | Une isoforme de la tenascine-c comme marqueur de neoplasies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6281335B1 (en) * | 1993-10-08 | 2001-08-28 | Coulter Corporation | Hybridoma and anti-KC-4 humanized monoclonal antibody |
DK0859841T3 (da) * | 1995-08-18 | 2002-09-09 | Morphosys Ag | Protein/(poly)peptidbiblioteker |
NZ332566A (en) * | 1996-05-22 | 2000-08-25 | Novopharm Biotech Inc | Antigen binding fragments that specifically detect cancer cells |
US6303323B1 (en) * | 1997-10-21 | 2001-10-16 | Cancer Research Campaign Technology Limited | Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies |
-
2002
- 2002-11-19 JP JP2003545672A patent/JP2005517388A/ja not_active Withdrawn
- 2002-11-19 CA CA002467020A patent/CA2467020A1/fr not_active Abandoned
- 2002-11-19 CN CNA028270959A patent/CN1615315A/zh active Pending
- 2002-11-19 EP EP02803674A patent/EP1446416A4/fr not_active Withdrawn
- 2002-11-19 WO PCT/US2002/037134 patent/WO2003044036A1/fr active Application Filing
- 2002-11-19 MX MXPA04004658A patent/MXPA04004658A/es not_active Application Discontinuation
- 2002-11-19 AU AU2002365978A patent/AU2002365978A1/en not_active Abandoned
- 2002-11-19 BR BR0214288-0A patent/BR0214288A/pt not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000032635A2 (fr) * | 1998-12-02 | 2000-06-08 | Ixsys, Incorporated | Anticorps monoclonaux humains specifiques de tumeurs et leur technique d'utilisation |
WO2000063699A1 (fr) * | 1999-04-20 | 2000-10-26 | Philogen S.R.L. | Une isoforme de la tenascine-c comme marqueur de neoplasies |
Non-Patent Citations (4)
Title |
---|
PANCOOK J D ET AL: "In vitro affinity maturation of human IgM antibodies reactive with tumor-associated antigens.", HYBRIDOMA AND HYBRIDOMICS. 2001, vol. 20, no. 5-6, 2001, pages 383 - 396, XP002348142, ISSN: 1536-8599 * |
PRAT M ET AL: "CAR-3 A MONOCLONAL ANTIBODY-DEFINED ANTIGEN EXPRESSED ON HUMAN CARCINOMAS", CANCER RESEARCH, vol. 45, no. 11 PART 2, 1985, pages 5799 - 5807, XP009055057, ISSN: 0008-5472 * |
See also references of WO03044036A1 * |
WU H ET AL: "STEPWISE IN VITRO AFFINITY MATURATION OF VITAXIN, AN ALPHAVBETA3-SPECIFIC HUMANIZED MAB", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 95, no. 11, 26 May 1998 (1998-05-26), pages 6037 - 6042, XP000918969, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
JP2005517388A (ja) | 2005-06-16 |
AU2002365978A1 (en) | 2003-06-10 |
MXPA04004658A (es) | 2004-08-13 |
BR0214288A (pt) | 2004-11-09 |
EP1446416A1 (fr) | 2004-08-18 |
CA2467020A1 (fr) | 2003-05-30 |
WO2003044036A1 (fr) | 2003-05-30 |
CN1615315A (zh) | 2005-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1432444A4 (fr) | Anticorps anti-a beta | |
HK1074206A1 (en) | Anti-trail-r antibodies | |
IL166244A0 (en) | Super humanized antibodies | |
IL156030A0 (en) | Humanized antibodies | |
AU1174702A (en) | Humanized anti-lt-beta-r antibodies | |
EP1391464A4 (fr) | Anticorps monoclonal anti-cd40 | |
EP1383801A4 (fr) | Anticorps contre le cancer | |
HK1153763A1 (en) | Anti-her2 antibody variants | |
EP1443963A4 (fr) | Composes de ciblage d'anticorps | |
HK1153649A1 (zh) | 治療性抗 單克隆抗體 | |
AU2003264009A8 (en) | Humanized rabbit antibodies | |
HUP0402333A3 (en) | Modified anti-tnf alpha antibody | |
AU2002365649A8 (en) | Anti-dota antibody | |
GB0126378D0 (en) | Antigen | |
EP1462456A4 (fr) | Antigenes tumoraux | |
EP1178829A4 (fr) | Anticorps monoclonal humain | |
IL158184A0 (en) | Anti-muc-1 single chain antibodies for tumor targeting | |
EP1454914A4 (fr) | Antigene de tumeur | |
EP1446416A4 (fr) | Anticorps monoclonaux specifiques de tumeur | |
EP1403283A4 (fr) | Antigenes tumoraux | |
FI20011055A0 (fi) | Heveiiniä sitovat monoklonaaliset vasta-aineet | |
GB0121727D0 (en) | Monoclonal antibodies | |
GB0003359D0 (en) | Monoclonal antibodies | |
GB0008160D0 (en) | Monoclonal antibodies | |
GB0119553D0 (en) | Antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040527 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20051018 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080603 |